- $35.86m
- -$41.23m
REG-Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG-The Vanguard Group, Inc. Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG-The Vanguard Group, Inc. Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-The Vanguard Group, Inc. Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG-The Vanguard Group, Inc. Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
Announcement